References
1. Yu J, Collier A-rY, Rowe M, et al. Neutralization of the SARS-CoV-2
Omicron BA.1 and BA.2 Variants. New England Journal of Medicine.2022.
2. Wilhelm A, Widera M, Grikscheit K, et al. Reduced Neutralization of
SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies.medRxiv. 2021:2021.2012.2007.21267432.
3. Cheng SMS, Mok CKP, Leung YWY, et al. Neutralizing antibodies against
the SARS-CoV-2 Omicron variant following homologous and heterologous
CoronaVac or BNT162b2 vaccination. Nature Medicine. 2022.
4. Wratil PR, Stern M, Priller A, et al. Three exposures to the spike
protein of SARS-CoV-2 by either infection or vaccination elicit superior
neutralizing immunity to all variants of concern. Nat Med. 2022.
5. Stegger M, Edslev SM, Sieber RN, et al. Occurrence and significance
of Omicron BA.1 infection followed by BA.2 reinfection. medRxiv.2022:2022.2002.2019.22271112.
6. van der Straten K, Guerra D, van Gils MJ, et al. Mapping the
antigenic diversification of SARS-CoV-2. medRxiv.2022:2022.2001.2003.21268582.